Filing Flows

Filing Flows › Coherus Oncology (CHRS) › Who owns the stock

Who owns Coherus Oncology (CHRS) stock

142 funds reported Coherus Oncology (CHRS) shares in their latest 13F filings, worth $104M in all. The largest holder is BlackRock ($16.8M). Last quarter 66 funds added to their stakes and 54 cut them.

Largest holders of CHRS (13F)Largest holders of CHRS (13F)BlackRock$16.8MTimothy G. Youngquist 2020 Irrevo…$15.8MVanguard Group$14.2MVanguard Capital Management LLC$8.3MGeode Capital Management, LLC$5.2MSamsara BioCapital, LLC$4.8MKohlberg Kravis Roberts & Co. L.P.$4.2MState Street$3.3MTwo Sigma Investments, LP$3.2MAlyeska Investment Group, L.P.$2.4M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock12,003,316$16.8Mincrease2026-06-30
Timothy G. Youngquist 2020 Irrevocable Trust13,050,623$15.8Munchanged2026-09-30
Vanguard Group10,028,893$14.2Mdecrease2025-12-31
Vanguard Capital Management LLC5,949,490$8.3Mincrease2026-06-30
Geode Capital Management, LLC3,685,567$5.2Mincrease2026-06-30
Samsara BioCapital, LLC3,428,571$4.8Munchanged2026-06-30
Kohlberg Kravis Roberts & Co. L.P.3,036,076$4.2Munchanged2026-06-30
State Street2,382,305$3.3Mincrease2026-06-30
Two Sigma Investments, LP2,259,412$3.2Mdecrease2026-06-30
Alyeska Investment Group, L.P.1,733,234$2.4Mdecrease2026-06-30
Hudson Bay Capital Management LP1,693,000$2.4Mdecrease2026-06-30
AQR Capital Management LLC1,330,201$1.9Mincrease2026-06-30
Charles Schwab Investment Management1,228,069$1.7Mincrease2026-06-30
Panagora Asset Management1,137,325$1.6Mnew2026-06-30
Northern Trust1,129,470$1.6Mincrease2026-06-30

Coherus Oncology's latest quarter

Coherus Oncology, Q2 2026: revenue $14.3M (+40% year over year), operating margin -226.0%, net loss $20.6M, operating cash flow −$62.1M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most CHRS stock?

By the latest 13F filings: BlackRock ($16.8M); Timothy G. Youngquist 2020 Irrevocable Trust ($15.8M); Vanguard Group ($14.2M); Vanguard Capital Management LLC ($8.3M); Geode Capital Management, LLC ($5.2M).

What is the short interest in CHRS?

12,452,177 shares were sold short at the 2026-10-15 settlement, -46.64% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.